Ovarian Serous Adenocarcinoma

• CLINICAL_TRIALS trial_result · 2026-07-13
  Clinical Trial Results: A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]

  Phase 1/2 trial results for TC-510 in advanced mesothelin-expressing cancers were terminated with posted results.

• CLINICAL_TRIALS research · 2026-03-16
  Clinical Trial Update: Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer [Phase 2]

  A Phase 2 clinical trial evaluating pembrolizumab in combination with bevacizumab, with or without the anti-CD40 agonist CDX-1140, for recur…

• CLINICAL_TRIALS research · 2025-07-16
  Clinical Trial Update: Evaluating the Efficacy of Hyperthermic Intraperitoneal Treatment to Enhance the Sensitivity of Immune Checkpoint Inhibitor in Patients With Advanced Ovarian Cancer： A Single-arm Study [Phase 2]

  Phase 2 single-arm trial evaluating whether hyperthermic intraperitoneal chemotherapy (HIPEC) can enhance the efficacy of immune checkpoint …

• CLINICAL_TRIALS trial_result · 2024-09-20
  Clinical Trial Update: Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) [Phase 2]

  Phase 2 Imperial College London study evaluating dual mTORC1/2 inhibition in advanced or recurrent epithelial ovarian, fallopian tube, or pr…

• CLINICAL_TRIALS trial_result · 2024-01-29
  Clinical Trial Update: A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors [Phase 1, Phase 2]

  Phase 1/2 first-in-human open-label dose-escalation study of a CSP-targeting functional antibody in solid tumors completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-11-06
  Clinical Trial Update: Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]

  Phase 2 clinical trial evaluating pembrolizumab, bevacizumab, and cyclophosphamide in recurrent ovarian, fallopian tube, or primary peritone…

• CLINICAL_TRIALS trial_result · 2019-09-17
  Clinical Trial Update: Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]

  Phase 2 trial evaluating elesclomol sodium with paclitaxel in patients with recurrent or persistent ovarian epithelial cancer, fallopian tub…

• CLINICAL_TRIALS research · 2015-04-30
  Clinical Trial Update: Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity

  A completed clinical trial update on developing immunological assays to evaluate tumor antigen-specific immunity. The study includes ovarian…